Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Biologics for the primary care physician: Review and treatment of psoriasis.
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP).
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Biologics for the primary care physician: Review and treatment of psoriasis.
Biologics for the primary care physician: Review and treatment of psoriasis. Dis Mon. 2019 Mar; 65(3):50.
View in:
PubMed
subject areas
Administration, Topical
Dermatology
Humans
Immunologic Factors
Physicians, Primary Care
Psoriasis
Review Literature as Topic
authors with profiles
Jerrold Leikin